CHAD MATHEWS: Open Payments
NPI 1184621427 · HERMITAGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 96 payments from 19 companies in 2025. Trend: 2023 $1,511 · 2024 $1,485 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $366 |
| UCB, Inc. | 25 | $249 |
| ABBVIE INC. | 9 | $139 |
| Amgen Inc. | 6 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| GENZYME CORPORATION | 2 | $71 |
| REVANCE THERAPEUTICS, INC. | 1 | $65 |
| Galderma Laboratories, L.P. | 3 | $56 |
| Organon LLC | 5 | $52 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $47 |
Products named: TREMFYA, Bimzelx, SKYRIZI, OTEZLA, DUPIXENT, COSENTYX, DAXXIFY, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
